arrow
A

Adriana Moreno-Rodríguez

universidad autónoma benito juárez de oaxaca
H指数:11
被引数:392

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biological Evaluation of Esters of 4-Carboxylate-1,2,3-triazine and Analogs as New Potential Anti-Mycobacterium tuberculosis Agents

4-羧酸酯-1,2,3-三嗪及其类似物的生物评价:作为新型潜在抗分枝杆菌结核病剂的潜力

2026-06-070
OA
Using the Scaffold of FDA-Approved Drugs with Trypanocidal Activity to Identify New Anti-Trypanosoma cruzi Agents: An In Silico and In Vitro Approach

利用具有抗锥虫活性的已获批药物的骨架来识别新型抗克氏锥虫剂:一种体外和体外方法

2026-04-180
OAAI
Identification of Novel Trypanosoma cruzi Cysteine Protease Inhibitors via Ligand-Based Virtual Screening of FDA-Approved Drugs with Trypanocidal Activity

通过基于配体的虚拟筛选鉴定具有抗锥虫活性的FDA批准药物的新型克氏锥虫半胱氨酸蛋白酶抑制剂

2026-02-270
OAAI
In Silico and In Vitro Identification of New Eugenol Derivatives as Inhibitors of the Spike SARS-CoV-2 Protein Interaction With the ACE2 Host Receptor

基于计算机和体外实验鉴定的新型丁香油酚衍生物作为SARS-CoV-2刺突蛋白与宿主ACE2受体的相互作用抑制剂

2025-12-040
PRE
Microwave-assisted synthesis, biological evaluation, and computational insights of novel S-substituted 5-(2-(phenylthio)pyridine-3-yl)-1,3,4-oxadiazole-2-thiol derivatives as multitarget antitubercular, antioxidant, antiprotozoal and antimicrobial agents

微波辅助合成、生物评价及计算分析的新型S-取代-5-(2-(苯硫基)吡啶-3-基)-1,3,4-噁二唑-2-硫醇衍生物作为多靶点抗结核、抗氧化、抗原虫和抗菌剂的用途

2025-10-190
PRE
Design, Synthesis, In Vitro and In Silico Biological Evaluation of New Pyridine-2,5-Dicarboxylates Esters Bearing Natural Source Fragments as Anti-Trypanosomatid Agents

设计、合成及体外和计算机生物学评价:源自天然产物的吡啶-2,5-二羧酸酯类衍生物作为抗锥虫病剂的研发

2025-09-280
OAAI
Antiparasitic Effect of Polyphenols and Terpenes from Natural Products Against Trypanosoma cruzi and Leishmania mexicana

天然产物中多酚和萜类化合物的抗寄生虫作用:针对克氏锥虫和利什曼原虫墨西哥亚种

2025-08-210
PRE
Nifuroxazide and 4-Hydroxybenzhydrazone Derivatives as New Antiparasitic (Trypanosoma cruzi and Leishmania mexicana) and Anti-Mycobacterium tuberculosis Agents

呋喃唑酮及其4-羟基苯肼盐衍生物作为新的抗寄生虫(克氏锥虫和墨西哥利什曼原虫)和抗分枝杆菌结核分枝杆菌剂

2025-05-070
OA
Repositioning FDA-Approved Sulfonamide-Based Drugs as Potential Carbonic Anhydrase Inhibitors in Trypanosoma cruzi: Virtual Screening and In Vitro Studies

重新定位FDA批准的磺胺类药物作为克氏锥虫中潜在的碳酸酐酶抑制剂的虚拟筛选与体外研究

2025-05-010
OA
Expanding the antiprotozoal activity and the mechanism of action of n-butyl and iso-butyl ester of quinoxaline-1,4-di-N-oxide derivatives against Giardia lamblia, Trichomonas vaginalis, and Entamoeba histolytica. An in vitro and in silico approach
2024-10-290
OAAI
Design, Synthesis, and In Vitro and In Silico Evaluation of 1,3,4-Oxadiazoles as Anti-Trypanosoma cruzi and Anti-Leishmania mexicana Agents

1,3,4-恶二唑作为抗克氏锥虫和抗墨西哥利什曼原虫药物的设计,合成以及体外和计算机评估

2024-10-230
PRE
Ligand- and Structure-Based Virtual Screening Identifies New Inhibitors of the Interaction of the SARS-CoV-2 Spike Protein with the ACE2 Host Receptor

基于配体和结构的虚拟筛选确定了SARS-CoV-2刺突蛋白与ACE2宿主受体相互作用的新抑制剂

2024-05-011
OAAI
Expanding the chemical space of ester of quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives as potential antitubercular agents

扩大quinoxaline-7-carboxylate 1,4-二-n-氧化物衍生物的酯作为潜在抗结核药的化学空间

2024-01-010
PRE